Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

SELL
$1.1 - $1.54 $36,868 - $51,616
-33,517 Closed
0 $0
Q4 2022

Aug 11, 2023

BUY
$1.67 - $2.35 $28,967 - $40,763
17,346 Added 107.27%
33,517 $62,000
Q4 2022

Feb 13, 2023

BUY
$1.67 - $2.35 $28,967 - $40,763
17,346 Added 107.27%
33,517 $62,000
Q3 2022

Aug 11, 2023

SELL
$1.81 - $2.76 $27,816 - $42,415
-15,368 Reduced 48.73%
16,171 $29,000
Q3 2022

Nov 03, 2022

BUY
$1.81 - $2.76 $29,269 - $44,631
16,171 New
16,171 $31,000
Q2 2022

Aug 15, 2022

SELL
$1.34 - $5.34 $42,262 - $168,418
-31,539 Closed
0 $0
Q1 2022

Aug 11, 2023

SELL
$4.58 - $6.8 $9,059 - $13,450
-1,978 Reduced 5.9%
31,539 $144,000
Q1 2022

May 20, 2022

SELL
$4.58 - $6.8 $37,803 - $56,127
-8,254 Reduced 20.74%
31,539 $144,000
Q4 2021

Feb 16, 2022

SELL
$5.23 - $7.18 $2,860 - $3,927
-547 Reduced 1.36%
39,793 $256,000
Q3 2021

Nov 12, 2021

SELL
$5.94 - $8.75 $11,808 - $17,395
-1,988 Reduced 4.7%
40,340 $250,000
Q2 2021

Aug 12, 2021

BUY
$7.54 - $9.79 $60,877 - $79,044
8,074 Added 23.57%
42,328 $339,000
Q1 2021

May 03, 2021

BUY
$4.76 - $11.25 $4,983 - $11,778
1,047 Added 3.15%
34,254 $330,000
Q4 2020

Feb 12, 2021

BUY
$2.43 - $5.42 $2,289 - $5,105
942 Added 2.92%
33,207 $160,000
Q2 2020

Aug 10, 2020

SELL
$1.33 - $3.63 $1,843 - $5,031
-1,386 Reduced 4.12%
32,265 $101,000
Q1 2020

May 15, 2020

BUY
$1.27 - $2.33 $22,381 - $41,061
17,623 Added 109.95%
33,651 $48,000
Q4 2019

Feb 14, 2020

SELL
$1.3 - $2.72 $24,005 - $50,227
-18,466 Reduced 53.53%
16,028 $33,000
Q2 2019

Aug 14, 2019

BUY
$2.05 - $4.32 $70,712 - $149,014
34,494 New
34,494 $149,000
Q1 2019

May 13, 2019

SELL
$1.79 - $3.12 $59,868 - $104,351
-33,446 Closed
0 $0
Q4 2018

Feb 14, 2019

SELL
$2.24 - $3.9 $3,731 - $6,497
-1,666 Reduced 4.74%
33,446 $86,000
Q3 2018

Nov 14, 2018

SELL
$3.58 - $4.9 $19,697 - $26,959
-5,502 Reduced 13.55%
35,112 $137,000
Q2 2018

Aug 14, 2018

BUY
$4.43 - $5.14 $2,352 - $2,729
531 Added 1.32%
40,614 $193,000
Q1 2018

May 15, 2018

SELL
$4.65 - $5.9 $5,979 - $7,587
-1,286 Reduced 3.11%
40,083 $208,000
Q4 2017

Feb 08, 2018

BUY
$4.32 - $5.52 $10,787 - $13,783
2,497 Added 6.42%
41,369 $191,000
Q3 2017

Nov 14, 2017

BUY
$4.35 - $5.25 $169,093 - $204,078
38,872
38,872 $205,000

Others Institutions Holding CMRX

About CHIMERIX INC


  • Ticker CMRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,622,896
  • Market Cap $85M
  • Description
  • Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...
More about CMRX
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.